help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Right arrow Return to article

Table 1. Deficiency in pituitary functions and hormone replacement therapy in the GHD patients

Deficiency in pituitary functions Hormone replacement therapy

Females
1 A, T, G Levothyroxine (100 µg), hydrocortisone (20 mg), estradiol (2 mg), levonorgestrel (150 µg)
2 A Cortisone acetate (7.5 mg)
3 A, T, G Hydrocortisone (25 mg), levothyroxine (137.5 µg), ethinyl estradiol (30 µg), levonorgestrel (150 µg)
4 T Levothyroxine (100 µg)
5 A, G Cortisone acetate (10 mg), ethinyl estradiol (30 µg), levonorgestrel (150 µg)
Males
6 A, T, G Cortisone acetate (12.5 mg), levothyroxine (125 µg), testosterone undeconoate (80 mg/day)
7 A, T, G Levothyroxine (175 µg), cortisone acetate (5 mg), testosterone esters (250 mg every 3 wk, im)
8 A, T, G Levothyroxine (125 µg), cortisone acetate (25 mg), testosterone esters (250 mg every 3 wk, im)
9 A, T, G Cortisone acetate (25 mg), levothyroxine (200 µg), testosterone undeconoate (160 mg/day)
10 A, T, G Cortisone acetate (10 mg), levothyroxine (50 µg), testosterone esters (250 mg every 3 wk, im)

A, ACTH; T, TSH; G, gonadotropins.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals